Sagimet Biosciences (SGMT) Research & Development (2022 - 2026)

Sagimet Biosciences' Research & Development history runs 5 years deep, the most recent figure standing at $7.0 million for Q1 2026.

• In Q1 2026, Research & Development fell 54.41% year-over-year to $7.0 million; the TTM figure through Mar 2026 stood at $30.7 million (down 36.72% YoY), while the FY2025 annual figure was $39.1 million, up 1.59% from the prior year.
• Research & Development was $7.0 million for Q1 2026 at Sagimet Biosciences, up from $6.7 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $15.3 million in Q1 2025 to a low of $4.5 million in Q1 2023.
• Historically, Research & Development has averaged $7.7 million across 5 years, with a median of $6.6 million in 2022.
• The sharpest annual moves came in 2025 and 2026: Research & Development soared 191.56% in 2025, then slumped 54.41% in 2026.
• A 5-year view of Research & Development shows it stood at $5.8 million in 2022, then dropped by 3.27% to $5.7 million in 2023, then soared by 151.34% to $14.2 million in 2024, then plunged by 52.63% to $6.7 million in 2025, then increased by 3.88% to $7.0 million in 2026.
• The last three Research & Development figures came in at $7.0 million (Q1 2026), $6.7 million (Q4 2025), and $9.7 million (Q3 2025), per Business Quant data.